Curaleaf Holdings (CURLF) Current Assets (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Current Assets of $448.6 million for Q4 2025, up 3.28% year-over-year from $434.4 million in Q4 2024, and up 3.28% quarter-over-quarter from $434.4 million in Q4 2024.
Curaleaf Holdings (CURLF) Current Assets (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $448.6 million for Q4 2025.
- In Q4 2025, Current Assets rose 3.28% year-over-year to $448.6 million; the TTM figure through Dec 2025 stood at $448.6 million (up 3.28% YoY), while the FY2025 annual figure was $448.6 million, up 3.28% from the prior year.
- Current Assets for Q4 2025 stood at $448.6 million, up from $434.4 million in the prior quarter.
- The five-year high for Current Assets was $978.0 billion in Q1 2022, with the low at -$2.5 billion in Q4 2022.
- The 5-year median for Current Assets is $719.5 million (2021), against an average of $65.7 billion.
- Peak annual rise in Current Assets reached 135828.6% in 2022, while the deepest fall reached 438.84% in 2022.
- Curaleaf Holdings' Current Assets stood at $726.6 million in 2021, then slumped by 438.84% to -$2.5 billion in 2022, then soared by 117.0% to $418.6 million in 2023, then increased by 3.77% to $434.4 million in 2024, then grew by 3.28% to $448.6 million in 2025.
- Business Quant data shows CURLF's Current Assets at $448.6 million in Q4 2025, $434.4 million in Q4 2024, and $3.1 billion in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 467.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 467.80 Mn |
| Dec 31, 2025 | 448.62 Mn |
| Dec 31, 2024 | 434.37 Mn |
| Sep 30, 2024 | 3.07 Bn |
| Jun 30, 2024 | 58,000.00 |
| Dec 31, 2023 | 418.60 Mn |
| Sep 30, 2023 | 483.79 Mn |
| Jun 30, 2023 | 463.43 Mn |
| Dec 31, 2022 | -2.46 Bn |
| Sep 30, 2022 | 920.77 Mn |
| Jun 30, 2022 | 933.63 Mn |
| Mar 31, 2022 | 977.98 Bn |
| Dec 31, 2021 | 726.62 Mn |
| Sep 30, 2021 | 906.51 Mn |
| Jun 30, 2021 | 805.53 Mn |
| Mar 31, 2021 | 719.48 Mn |
| Dec 31, 2020 | 417.86 Mn |
| Sep 30, 2020 | 376.87 Mn |
| Dec 31, 2019 | 149.53 Mn |